Cite
P.3.c.017 Polish patients of the EUFEST study after 1 year antipsychotic treatment: drug discontinuation and metabolic syndrome parameters
MLA
Marek Jarema, et al. “P.3.c.017 Polish Patients of the EUFEST Study after 1 Year Antipsychotic Treatment: Drug Discontinuation and Metabolic Syndrome Parameters.” European Neuropsychopharmacology, vol. 20, Aug. 2010, p. S467. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ecacb4fc8d48833e7cfe025a0f39e5a1&authtype=sso&custid=ns315887.
APA
Marek Jarema, Janusz K. Rybakowski, T. Pawelczyk, Marcin Olajossy, & Jolanta Rabe-Jabłońska. (2010). P.3.c.017 Polish patients of the EUFEST study after 1 year antipsychotic treatment: drug discontinuation and metabolic syndrome parameters. European Neuropsychopharmacology, 20, S467.
Chicago
Marek Jarema, Janusz K. Rybakowski, T. Pawelczyk, Marcin Olajossy, and Jolanta Rabe-Jabłońska. 2010. “P.3.c.017 Polish Patients of the EUFEST Study after 1 Year Antipsychotic Treatment: Drug Discontinuation and Metabolic Syndrome Parameters.” European Neuropsychopharmacology 20 (August): S467. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ecacb4fc8d48833e7cfe025a0f39e5a1&authtype=sso&custid=ns315887.